COMMUNIQUÉS West-GlobeNewswire

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

14/06/2024 - 22:05

SAN FRANCISCO, June 14, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies [...]

Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024

14/06/2024 - 22:01

Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, [...]

Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)

14/06/2024 - 19:41

The Phase 3 study results are being published in PAIN® Journal, which is the leading journal devoted to pain medicine and research. PAIN is the official journal of the International Association for the Study of Pain, [...]

Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18

14/06/2024 - 19:40

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. , (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is [...]

Chiesi Global Rare Diseases Showcases Ongoing Commitment to Multiple Rare Diseases Communities at ENDO 2024 Meeting Debut

14/06/2024 - 17:57

• Results presented from a large, pooled database from three Phase 3 clinical trials evaluating MYCAPSSA (octreotide) for the treatment of people living with acromegaly • Additional presentations provide insights into [...]

Positron Corporation Joins Cardiac PET Industry Coalition (CPIC)

14/06/2024 - 17:38

Niagara Falls, NY, June 14, 2024 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company offering PET and PET-CT (Positron Emission [...]

LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial

14/06/2024 - 17:00

Clinical trial to test recent findings that show LIXTE’s lead clinical compound, LB-100, increases recognition of colon cancer cells by the immune system PASADENA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- LIXTE [...]

Renovaro, Inc. Announces $10 million in Equity Committed

14/06/2024 - 15:06

LOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- Renovaro, Inc. (NASDAQ: RENB) (the “Company”) announces that it has $10 million in additional equity committed at a price per share of $1.4726 and 10 percent warrant [...]

CMS Improves Star Ratings to 3.5 Stars for Clover Health PPO Medicare Advantage Plans for 2025 Payment Year

14/06/2024 - 15:00

The Company previously communicated that CMS had calculated a rating of 3.0 Stars for its PPO plans, impacting payment year 2025. As a result of a recent rating recalculation, CMS has improved that rating to 3.5 Stars [...]

PatchMD Releases Medical Weight Loss Resources with Expert-Reviewed Articles on GLP-1 Agonists

14/06/2024 - 15:00

Las Vegas, NV, June 14, 2024 (GLOBE NEWSWIRE) -- PatchMD, a leader in innovative vitamin supplement delivery, is excited to announce the release of a series of comprehensive resources designed to support individuals on [...]

OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data License Agreement

14/06/2024 - 14:45

Partner’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies MINNEAPOLIS, June 14, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation ( [...]

Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis

14/06/2024 - 14:45

MRT-6160, a VAV1-directed molecular glue degrader (MGD), inhibits disease progression, pro-inflammatory cytokines and autoantibody production in a model of rheumatoid arthritis Initiation of MRT-6160 Phase 1 SAD/MAD [...]

FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc.

14/06/2024 - 14:30

Acquisition expected to be synergistic with FOXO’s epigenetic technology in community health and addiction recovery settings as well as contribute significant cash flow MINNEAPOLIS, MN, June 14, 2024 (GLOBE NEWSWIRE [...]

Sienna Announces June Dividend

14/06/2024 - 14:30

MARKHAM, Ontario, June 14, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]

TALVEY®▼ (talquetamab) demonstrated highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma

14/06/2024 - 14:10

24-month overall survival rate of 67 percent achieved with talquetamab 0.8mg/kg biweekly dosing in the Phase 1/2 MonumenTAL-1 study 1 BEERSE, BELGIUM , June 14, 2024 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a [...]

GRI Bio Announces Reverse Stock Split

14/06/2024 - 14:05

GRI’s common stock is expected to begin trading on a post-split adjusted basis on June 18, 2024 LA JOLLA, CA, June 14, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology [...]

Disc Medicine Announces Underwritten Offering of Common Stock

14/06/2024 - 14:03

WATERTOWN, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments [...]

ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)

14/06/2024 - 14:03

A novel and innovative approach to treating metastasized cancer, starting with the very lethal grade 4 pancreatic cancer. Earlier this year, scientists from Columbia University in New York demonstrated that the growth [...]

Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress

14/06/2024 - 14:00

REDWOOD CITY, Calif., June 14, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]